Nanjing Vcare Was Certified as the "Nanjing Engineering Technology Research Center in 2024"

2024-07-22

Recently, the Nanjing Municipal Science and Technology Bureau announced the list of the Nanjing Engineering Technology Research Centers certified in 2024. The "Nanjing Engineering Technology Research Center for Synthetic Biology and Flow Chemistry" constructed by Nanjing Vcare has been recognized as the "Nanjing Engineering Technology Research Center".

The Nanjing Engineering Technology Research Center is a R&D organization with relatively strong R&D and comprehensive strength. It focuses on the major strategic development fields of the country and the industry, aiming to improve the independent innovation ability, enhance the core competitiveness and development potential of the industry. It is mainly a scientific R&D entity established for key scientific research institutions, key enterprises and institutions of higher education with relatively strong scientific and technological strength in relevant industries or fields in Nanjing. Its establishment is intended to guide enterprises to further promote technological innovation and the transformation of achievements through the establishment of engineering research centers.

The "Nanjing Engineering Technology Research Center for Synthetic Biology and Flow Chemistry" is a one-stop solution established by Nanjing Vcare for forward-looking research layout to develop and apply new synthetic methods and promote the industrial upgrading of chemical synthesis. Its main purpose is to develop green and low-carbon production technologies for active pharmaceutical ingredients. This engineering technology research center has built platforms for synthetic biology and enzyme-catalyzed conversion technology as well as continuous flow chemistry technology, and established multiple technologies such as the development platform for synthetic biology and enzyme-catalyzed technology, the development of supported catalysts, fixed-bed hydrogenation technology and microchannel reaction technology. It has achieved a number of research achievements in the innovation and upgrading of production technologies for active pharmaceutical ingredients and advanced pharmaceutical intermediates as well as in green synthesis. These achievements have been applied to optimize the synthesis process routes of multiple products and realize large-scale industrialization, solving problems in current traditional chemical synthesis such as complex technical reaction routes, low efficiency in asymmetric synthesis, harsh reaction conditions, high safety risks and serious environmental pollution, achieving cost reduction and efficiency improvement, and promoting the development of green, safe, efficient and sustainable synthetic methods.

The approval of the "Nanjing Engineering Technology Research Center" this time is not only a full recognition of the comprehensive strength of Nanjing Vcare's R&D team and technological innovation ability, but also a strong impetus for the company to continuously improve its R&D ability, develop green chemistry, accelerate technological innovation and the transformation of scientific and technological achievements. Taking this opportunity, Nanjing Vcare will accelerate the construction of the scientific and technological innovation technology R&D platform, continuously promote R&D and innovation work, actively explore the green and low-carbon transformation of the industry and the innovation and upgrading of production technologies, and promote the high-quality development of the enterprise.

Prev

A Delegation Led by the Global Vice President of Thermo Fisher Scientific Visited Nanjing Vcare

Next

Nanjing Vcare Won the Title of "Top 20 Chinese Pharmaceutical CRO Enterprises" Again